ABSTRACT
Follicular lymphoma (FL) is a common B-cell lymphoma of germinal center B-cell origin. Approximately 20% of all lymphoma cases are diagnosed as FL. 1 Current recommended histologic grading according to the 2017 World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues continues to use criteria adapted from the original Mann-Berard criteria, 2 which are based on the average number of large transformed cells or centroblasts in 10 high-power fields (hpf) from 10 random and representative neoplastic follicles. Those with five or fewer centroblasts/hpf are designated as grade 1, with six to 15 centroblasts/hpf as grade 2, and with more than 15 centroblasts/hpf as grade 3. Grade 3 FL is further subdivided into grades 3A and 3B, based on the presence (3A) or absence (3B) of centrocytes. FLs designated as grades 1 and 2 are considered low grade, while grade 3 is high grade. 3 There is a significant difference in treatment between low-grade and high-grade FLs, as established by the National Comprehensive Cancer Network (NCCN) guidelines; therefore, the ability to accurately distinguish between the two grades is vital. On the other hand, there is still controversy regarding the clinical significance of subdividing high-grade FL. Some more recent investigations do suggest a difference both biologically and clinically between grade 3B FL and the other FL grades. In a study by Horn et al, 4 3B FL was shown to have cytogenetic and immunohistochemical features more in line with diffuse large B-cell lymphoma (DLBCL) than other FLs. Another study found the clinical course of 3B FL to resemble DLBCL, with the possibility of cure after therapy, 5 while yet another study found no difference in outcome between grades 3A and 3B. 6 Although several studies suggest that the current grading system predicts which FLs may behave more aggressively, the clinical significance and best method of grading are still controversial. However, the WHO deems there to be insufficient evidence to recommend an alternative method, and therefore, although certainly not free of problems, centroblast count in 10 random (representative) follicles has remained the recommended system of grading. One obvious issue with using the cutoff values determined by Mann and Berard as described by the 2017 WHO is that there is no mention of field of view. The cutoffs set by Mann and Berard apply to an hpf of 0.159 mm 2 , which correlates to a ×40 objective with an 18-mm field number ocular. However, microscopes now often use oculars with 20-or 22-mm field numbers. To accurately correlate with Mann and Berard's cutoffs, when using an ocular with a field number other than 18 mm, one would need to convert the count to centroblasts/0.159 mm 2 . For example, if using a 22-mm field number ×10 ocular, you would need to count only 7 hpf and then divide by 10 or count 10 hpf and then divide by 15. Yet this is not specifically addressed and therefore is not often done. Another overarching concern associated with centroblast count is the high interobserver variability and therefore lack of reproducibility. [7] [8] [9] [10] To help ameliorate this problem, several studies have assessed the value of proliferation rate in FL, mainly focusing on H&E mitotic count (MC) and/or Ki-67 proliferation index (PI). These studies all reached a similar conclusion, in that there is significant prognostic value in assessing proliferative rate in FL. 11, 12 In the study by Wang et al, 13 18% of their low-grade FL (LGFL) cases actually had high Ki-67 PIs (LG-HPI) with a higher early death rate than in LGFL cases with low PI, leading them to propose classifying them separately. These data led the WHO to recommend Ki-67 PI assessment as a useful adjunct in evaluating cases of FL in the 2008 fourth edition 14 and to continue this recommendation in the 2017 revised fourth edition. 3 However, both H&E MC and Ki-67 PI also suffer from high interobserver variability. 11, 12 Besides the inherent differences among individual pathologists, these methods are also affected by technical differences. Darker H&E staining can make searching for mitotic figures difficult. The presence of apoptotic bodies can be confused with mitotic figures on H&E. Nonspecific background staining and variable staining intensity can lead to problems with Ki-67 interpretation. Therefore, although prognostically significant, the issue of interobserver variability still remains.
Phosphohistone H3 (PHH3) is a commercially available antibody targeted against phosphorylated histone H3, a core histone protein that becomes increasingly phosphorylated during chromatin condensation as a cell moves from the late G2 phase to the M phase. Differences in staining pattern allow the observer to differentiate cells in the G2 phase (speckled nuclear staining) from the M phase (diffuse, clumpy staining). Due to these properties, PHH3 is considered a mitotic-specific immunohistochemical (IHC) stain. 15, 16 PHH3 has been studied and found useful in detecting mitotic figures in the analysis of many tumors, such as those of neurologic, 17, 18 breast, 19, 20 melanocytic, 21, 22 pancreatic, 23 and uterine 24 origins. As a mitotic-specific IHC marker, PHH3 allows for easy and more precise recognition of cells in mitosis. It does not stain apoptotic bodies. Our study assesses the utility of performing a mitotic count with the aid of PHH3 immunohistochemistry in cases of FL. We assess its correlation with histologic grade based on centroblast count as well as the degree of interobserver variability compared with that seen with H&E MC and Ki-67 PI. To our knowledge, this is only the second study to date investigating the utility of PHH3 MC in grading FL.
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Materials and Methods
Patients and Samples
Patient identification and retrieval of tissue blocks and slides began after institutional review board approval. Cases of FL initially diagnosed at Brooke Army Medical Center between January 1, 2005, and April 1, 2017, were identified using a Copath natural language search. There were 57 cases identified. Inclusion criteria included patient age older than 18 years and younger than 89 years at the time of diagnosis, at least 10 neoplastic follicles present to evaluate, and enough residual tissue present to perform the needed additional IHC stains (Ki-67 and/ or PHH3). If the sample had an additional diagnosis of DLBCL (one in total), a distinct area of FL was required to remain in the study. Samples were excluded if no grade was given at the time of initial diagnosis. A representative H&E section was selected for each case meeting inclusion/ exclusion criteria. Additional IHC staining with PHH3 and/or Ki-67 was performed as needed on the chosen representative slide. All H&E and IHC stains were performed on 4-µm thickness tissue sections from formalin-fixed, paraffin-embedded tissues. Each case was deidentified and randomized. All hematopathologists used an Olympus BX46 microscope with a field number of 22. At ×400 total magnification, this gives a field diameter of 0.55 mm and a field area of 0.237 mm 2 . A board-certified hematopathologist reinterpreted each case of FL based on the chosen representative slide and assigned a grade based on centroblast count. If there was a discrepancy with the originally assigned grade, a second hematopathologist interpreted the slide and assigned a grade. If two of the three interpretations agreed, the agreement was used to assign a histologic grade for the study. If all three interpretations differed, the case was excluded from the study. Three hematopathologists individually assessed each study case for H&E MC, Ki-67 PI, and PHH3 MC, blinded to the others' interpretations.
H&E Centroblast Count Interpretation
H&E centroblast count was recorded as the average number of centroblasts counted within 10 random (representative) neoplastic follicles at ×400 total magnification (total field area counted for 10 follicles = 2.37 mm 2 ). Centroblasts were defined as described in the 2017 WHO as large cells, typically greater than or equal to three times the size of a small mature lymphocyte, with vesicular nuclei containing one or multiple, peripherally located nucleoli ❚Image 1❚. Immunoblasts were defined as large cells with a single prominent central nucleolus and were not counted. Although only present in a minority of cases and in small quantities, large cleaved cells and polylobated cells were only counted if nucleoli were present.
H&E MC Interpretation
H&E MC was recorded as the average number of mitotic figures counted within 10 representative neoplastic follicles at ×400 total magnification (total field area counted for 10 follicles = 2.37 mm 2 ).
Ki-67 and PHH3 Immunohistochemistry and Interpretation
A Ventana BenchMark ULTRA automated stainer and Ventana ultraView detection system (Ventana Medical Systems) were used according to the manufacturer's instructions for deparaffinization, cell conditioning, and staining for Ki-67 (CONFIRM anti-Ki-67, monoclonal, prediluted to 2 µg/mL; Ventana Medical Systems) and PHH3 (polyclonal, prediluted; Cell Marque). Ki-67 was considered positive in cells with any intensity of purely nuclear staining. Ki-67 PI was recorded as the overall estimated percentage of FL cells staining positive within 10 or more neoplastic follicles, with correlation to the H&E slide as needed to exclude nonlymphomatous cells. PHH3 was considered positive in cells showing strong, intense staining of chromatin clumps. Staining consistent with the G2 phase (speckled nuclear staining with an intact nuclear membrane) was not counted. The PHH3 mitotic count was recorded as the average number of PHH3-positive FL cells in 10 random and representative neoplastic follicles at ×400 total magnification. Positive and negative controls were evaluated alongside the cases and deemed appropriately reactive.
Statistical Analysis
H&E MC, Ki-67 PI, and PHH3 MC were correlated to centroblast count (grade) using a Pearson correlation. The difference between mitotic counts based on H&E vs PHH3 was assessed using a two-tailed t test. The correlation between FL histologic grade by centroblast count and both H&E and PHH3 mitotic counts was assessed by a linear regression. Agreement/interobserver variability among pathologists was calculated using an intraclass correlation coefficient (ICC). The sensitivity and specificity of PHH3 MC, Ki-67 PI, and H&E MC for FL grade were calculated and then compared using a receiver operating characteristic (ROC) curve.
Results
Forty-five cases met inclusion criteria and underwent histologic evaluation. Two cases were excluded due to the inability to resolve the discrepancy between the original grade and reinterpretation by two hematopathologists, leaving a total of 43 cases included in data analysis. Histologic interpretation resulted in 26 LGFLs (eight ❚Image 1❚ Four centroblasts (arrows) (H&E, ×1,000). 3B) . Thirty-nine of these were excisional biopsy specimens and four were needle core biopsy specimens, all meeting the inclusion criteria of having at least 10 neoplastic follicles present to evaluate. The mean patient age was 60 years (range, 28-80 years). Sixteen were male and 27 were female.
Staining Patterns
H&E staining allows for the morphologic classification of lymphoma cells as either centrocytes (small, cleaved) or centroblasts (large with multiple peripherally localized nucleoli) (see Image 1). Mitotic figures generally correspond to areas of darker and more compact basophilic staining resembling stages of mitosis. PHH3 immunohistochemistry highlights mitotic figures as dark and dense chromatin clumps within cells against a light blue background. Staining intensity is relatively uniform and consistently strong. G2 phase staining of PHH3 is speckled and intranuclear and typically of weaker intensity ❚Image 2❚. Ki-67 immunohistochemistry shows positivity in more cells than PHH3, with variable staining intensity. Examples of H&E staining and PHH3 and Ki-67 IHC stains for LGFL and HGFL cases are depicted in ❚Image 3❚.
Sensitivity and Specificity for Histologic Grade
Based on the compiled ROC curve ❚Figure 1❚, a PHH3 of 3.17 or more had the strongest specificity (80.8%) and a sensitivity of 94.1% for HGFL. Ki-67 of 17.5% or higher corresponded to HGFL with 94.1% sensitivity and 61.5% specificity. H&E MC of 0.52 or more corresponded to HGFL with 88.2% sensitivity and 57.7% specificity.
Correlation of PHH3 MC, H&E MC, and Ki-67 PI With Histologic Grade Category
The PHH3 MC resulted in the strongest correlation to grade (r = 0.701, P < .0001) compared with Ki-67 PI (r = 0.681, P < .0001) and H&E MC (r = 0.536, P = .0002) and the strongest linear relationship to centroblast count (R 2 = 0.453) ❚Figure 2❚. Ten total cases of LGFL (all grade 2) had an average Ki-67 PI of more than 17.5%. Five were more than 30% (12% frequency) and could be considered LG-HPI based on the cutoffs proposed by Wang et al. 13 Of the 10 total, six (60%) had an average PHH3 of less than 3.17 and therefore were more consistent with LGFL based on our cutoff value of 3.17 for best combined sensitivity and specificity for HGFL. One case morphologically diagnosed as grade 2 showed a very high average Ki-67 PI (82%). The average PHH3, however, was 3.1, more consistent with LGFL, although just barely below our chosen cutoff value. This case was an extranodal abdominal FL. A review of the patient's clinical record revealed initial treatment with radiation and a relapse 2 years after diagnosis within a cervical lymph node. She was further treated with a chemotherapy regimen including rituximab, cyclophosphamide, vincristine, and prednisone followed by maintenance rituximab for 2 years with no evidence of disease by surveillance imaging in the following 9 years. One HGFL case had an average Ki-67 PI of less than 17.5% but with an average PHH3 of more than 3.17. Four cases of LGFL had an average PHH3 MC of more than 3.17. One case of HGFL had an average PHH3 MC of less than 3.17. Of the 43 cases, 12 (28%) showed a difference in the assigned morphologic grade by centroblast count and the theoretical grade assigned by Ki-67 PI only (11/12), PHH3 MC only (1/12), and both Ki-67 PI and PHH3 MC (4/12). In the remaining 31 (72%) cases, there was agreement between proliferation assessment by Ki-67 and PHH3 and traditional histologic grading.
Comparison of PHH3 MC, H&E MC, and Ki-67 PI Based on Histologic Grade Category
The PHH3 MC was consistently higher than the H&E MC with a mean PHH3 MC of 2.16 for LGFL and 6.72 for HGFL (difference = 4.56, P < .0001) compared with a mean H&E MC of 0.66 for LGFL and 2.12 for HGFL (difference = 1.46, P = .0038). The mean Ki-67 PI ❚Image 2❚ Staining patterns of phosphohistone H3. Strong, clumpy, and dense immunopositivity of a mitotic figure (top). Weak, speckled, and intranuclear staining of the G2 phase (bottom).
for LGFL was 18.8 compared with 47.0 for HGFL (difference = 28.2, P < .0001). ❚Table 1❚ compares LGFL and HGFL means, ranges, and statistical significance for each variable evaluated, and ❚Figure 3❚ shows the actual average mean values calculated for each FL grade.
Interobserver Variability
Forty-five cases were initially evaluated, but, as described earlier, two were excluded due to inability to resolve the discrepancy between the original histologic grade and reinterpretation by two hematopathologists. Of the 43 cases of FL included in the study, 19 (44.2%) cases had a discrepancy between the original grade and reinterpretation that was resolved after a second hematopathologist's evaluation. Agreement among pathologists was strongest for PHH3 MC (ICC = 0.86) followed by Ki-67 PI (ICC = 0.85) and H&E MC (ICC = 0.78).
Discussion
Determination of histologic grade in FL is important for several reasons. Although the actual prognostic implications of morphologic grade in FL remain controversial, histologic grade does have a known predictive value regarding behavior of the lymphoma.
LGFLs are typically associated with asymptomatic to mildly symptomatic disease and an indolent course. HGFLs are more likely to behave aggressively (similar to that of DLBCL). Gene expression profiling studies have also shown distinctly different profiles for low-grade and high-grade FLs, providing additional support for their difference in behavior. 10 Since grade predicts behavior, grade also plays a role in choice of treatment. HGFLs are often treated similarly to DLBCL, with immediate chemotherapy and curative intent. An intensive chemotherapy regimen such as rituximab (Rituxan), cyclophosphamide (Cytoxan), doxorubicin (Doxil), vincristine (Oncovin), and prednisone (Deltasone) is typically chosen. On the other hand, grade 1 to 2 FLs are typically watched unless the patient is symptomatic. If there is an indication for treatment of an LGFL, the therapy is generally less intense, such as rituximab alone or rituximab combined with bendamustine. 26 The morphologic assessment of centroblast count is considered the gold standard for histologic grading of FLs and has been widely accepted and used for years. Unfortunately, it suffers strongly from high interobserver variability, as demonstrated in our study, where 46.7% of cases showed a discrepancy between the original grade and reinterpretation. Although performing a Ki-67 PI suffers from high interobserver variability and is currently not required by the WHO and not included in NCCN treatment guidelines, Ki-67 PI has been recommended by the WHO as an adjunct to histologic grading. Performing a Ki-67 PI allows for recognition of cases of low-grade morphology with a high (≥30%) Ki-67 PI, described by Wang et al 13 as LG-HPI at a frequency of around 18% of FL cases, which have been shown to behave more aggressively. 13 In such cases, some hematologists/oncologists may take the Ki-67 PI into consideration when deciding whether to observe or initiate therapy for patients with low-grade FL. On the other hand, many of the reasons for high interobserver variability in Ki-67 PI assessment (a high number of cells staining, variable staining intensity) are mitigated when using PHH3 MC since PHH3 is a mitotic-specific marker, stains fewer cells than Ki-67, and generally stains with a consistently strong intensity. This study compared the interobserver variability between Ki-67 PI, PHH3 MC, and H&E MC and found PHH3 to have the lowest variability.
One pertinent side note is the fact that even though monoclonal antibodies tend to have generally less background staining and show greater lot-to-lot consistency, several studies, as well as ours, including the previously mentioned study of PHH3 in FL by Bedekovics et al 25 and studies on various other disease entities, 17, 18 have used a polyclonal PHH3 antibody and found this to give satisfactory, easily interpretable results. Although different clones were used with different detection kits for many of these studies, all came to the similar conclusion that PHH3 evaluation shows less interobserver variability than Ki-67 PI. Therefore, it is reasonable to conclude that differences in the type of antibody and detection methods used will not fundamentally affect results. Although all variables showed a wide variation in range as well as overlap in values found for LGFL and HGFL, PHH3 showed the best correlation with histologic grade and the best linear relationship with centroblast count. The best combination of sensitivity and specificity for HGFL was also achieved using PHH3. Although PHH3 MC, Ki-67 PI, and H&E MC were all found to correlate well with each other and to histologic grade, 28% of study cases showed a discrepancy between grade assigned by our chosen cutoff values for 
Conclusions
These data support PHH3 as a useful aid in assessing FL grade. Regarding categorization of FL cases, PHH3 correlates best to histologic grade, has the best combination of sensitivity and specificity for HGFL, and has less interobserver variability compared with Ki-67 PI and H&E MC. Therefore, PHH3 may be especially useful to help categorize cases where centroblast count is near the cutoff value for HGFL. Our data also suggest that PHH3 MC may also be high (>3.17) in cases of FL with lowgrade morphology but with high Ki-67 PI. Further study of the prognostic value of PHH3 is needed to assess the full value of this marker in FL. If further studies show a similar prognostic value to Ki-67 PI, these data support the use of PHH3 either alone or in combination with Ki-67 PI due to its superior reproducibility.
